Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells

Cancer Chemotherapy and Pharmacology

Volumn 57, Issue 6, 2006, Pages 741-754

  Matesic, Diane F ^a   Villio, Kimberly N ^a   Folse, Stacey L ^a   Garcia, Erin L ^a   Cutler, Stephen J ^a   Cutler, Horace G ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Akt kinase; Cytokinesis; Multinucleate; Oncogene

Indexed keywords

ANTINEOPLASTIC AGENT; CHAETOGLOBOSIN K; CONNEXIN 43; GAP JUNCTION PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL CYCLE ARREST; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINESIS; CYTOSOL; DRUG MECHANISM; FLUORESCENCE MICROSCOPY; GAP JUNCTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CYTOKINESIS; EPITHELIAL CELLS; INDOLE ALKALOIDS; LIVER; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); RATS;

EID: 33645750941     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0113-5     Document Type: Article

References (37)

1. Adjei AA (2001) Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 93:1062-1074
2. Ahmadian MR (2002) Prospects for anti-ras drugs. Br J Haematol 116:511-518
3. Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3:7-13
4. Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ, Counter CM (2002) Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 16:2045-2057
5. Cesen-Cummings K, Warner KA, Ruch RJ (1998) Role of protein kinase C in the deficient gap junctional intercellular communication of K-ras-transformed murine lung epithelial cells. Anticancer Res 18:4343-4346
6. Kolch W (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351:289-305
7. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467
8. Urano, T, Emkey R, Feig LA (1996) Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J 15:810-816
9. el-Fouly MH, Trosko JE, Chang CC, Warren ST (1989) Potential role of the human Ha-ras oncogene in the inhibition of gap junctional intercellular communication. Mol Carcinog 2:131-135
10. de Feijter AW, Ray JS, Weghorst CM, Klaunig JE, Goodman JI, Chang CC, Ruch RJ, Trosko JE (1990) Infection of rat liver epithelial cells with v-Ha-ras: correlation between oncogene expression, gap junctional communication, and tumorigenicity. Mol Carcinog 3:54-67
11. Tikoo A, Cutler H, Lo SH, Chen LB, Maruta H (1999) Treatment of Ras-induced cancers by the F-actin cappers Tensin and Chaetoglobosin K, in combination with the Caspase-1 inhibitor N1445. Cancer J Sci Am 5:293-300
12. Hancock JF, Magee AI, Childs JE, Marshall CJ (1989) All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57:1167-1177
13. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ (1992) Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci USA 89:6403-6407
14. Ruch RJ, Sigler K (1994) Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve ras plasma membrane association. Carcinogenesis 15:787-789
15. Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y (1998) Dislodgment and accelerated degredation of Ras. Biochem 37:1306-1314
16. Kip1 and G1 cell cycle arrest. Eur J Biochem 270:2759-2772
17. Cutler HG, Crumley F, Cox R (1980) Chaetoglobosin K: a new plant growth inhibitor and toxin from Diplodia macrospora. J Agric Food Chem 28:139-142
18. Matesic DF, Blommel ML, Sunman JA, Cutler SJ, Cutler HG (2001) Prevention of organochlorine-induced inhibition of gap junctional communication by chaetoglobosin K in astrocytes. Cell Biol Toxicol 17:395-408
19. Schanne FA, Kane AB, Young EE, Farber JL (1979) Calcium dependence of toxic cell death: a final common pathway. Science 206:700-702
20. Matesic DF, Rupp HL, Bonney WJ, Ruch RJ, Trosko JE (1994) Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells. Mol Carcinog 10:226-236
21. Laemmli NK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
22. Goldman F, Hohl RJ, Crabtree J, Lewis-Tibesar K, Koretzky G (1996) Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. Blood 88:4611-4619
23. Ruch RJ, Madhukar BV, Trosko JE, Klaunig JE (1993) Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Mol Carcinog 7:50-59
24. de Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC, Trosko JE (1996) Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinog 16:203-212
25. Na HK, Wilson MR, Kang KS, Chang CC, Grunberger D, Trosko JE (2000) Restoration of gap junctional intercellular communication by caffeic acid phenethyl ester (CAPE) in a ras-transformed rat liver epithelial cell line. Cancer Lett 157:31-38
26. Sunman JA, Foster MS, Folse SL, May SW, Matesic DF (2004) Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid. Mol Carcinog 41:231-246
27. Na HK, Chang CC, Trosko JE (2003) Growth suppression of a tumorigenic rat liver cell line by the anticancer agent, ET-18-O-CH(3), is mediated by inhibition of cytokinesis. Cancer Chemother Pharmacol 51:209-215
28. Musil LS, Goodenough DA (1991) Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap-junctional plaques. J Cell Biol 115:1357-1374
29. Cross DA, Alessi DR, Cohen P, Andjelkovic M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-788
30. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541-6551
31. Maira SM, Galetic I, Brazil DP, Kaech S, Ingley E, Thelen M, Hemmings BA (2001) Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 294:374-379
32. Vivanco I, Sawyers CI (2002) The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nature Rev 2:489-501
33. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PRJ, Reese CB, McCormick F, Tempst P, Coadwell J, Hawkins PT (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-triphosphate- dependent activation of protein kinase B. Science 279:710-714
34. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI (2002) Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 8:1168-1171
35. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM (2004) Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 64:5232-5236
36. Hartwig, JH, Bokoch GM, Carpenter CL, Janmey PA, Taylor LA, Toker A, Stossel TP (1995) Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82:643-653
37. Yahara I, Harada F, Sekita S, Natori S, Yoshihira K (1982) Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro. J Cell Biol 92:69-87